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Abstract—Maladaptive arterial remodeling may constitute a mechanism underlying the risk of stroke in individuals with
the metabolic syndrome (MetS), but evidence supporting this contention derives from cross-sectional studies only. We,
therefore, investigated, in apparently healthy adults, whether changes in MetS status between the ages of 36 and 42 years
(never [n207, reference group], incident [n31], recovery [n23], and persistent [n32]) were associated with
changes in carotid interadventitial diameter, lumen diameter, intima-media thickness, circumferential wall tension and
stress, and Young’s elastic modulus. All data analyses were adjusted for sex, height, and (changes in) age, lifestyle
variables, low-density lipoprotein cholesterol, and use of antihypertensive medication. At baseline and as compared with
the reference group, individuals with persistent MetS had significantly higher interadventitial diameter, circumferential
wall tension, circumferential wall stress, and Young’s elastic modulus but not intima-media thickness. In the course of
follow-up, these individuals (versus reference group) displayed significantly steeper increases in intima-media thickness
(0.011 versus 0.005 mm/y), which were accompanied by significantly steeper increases in interadventitial diameter
(0.077 versus 0.032 mm/y) and lumen diameter (0.055 versus 0.023 mm/y) but not circumferential wall stress, which
decreased (0.34 versus 0.12 kPa/y). These findings suggest that increases in intima-media thickness in young adults
with the MetS may primarily reflect an adaptive mechanism that attempts to restore local hemodynamic conditions to
an equilibrium rather than atherosclerosis, per se. However, carotid adaptations did not restore circumferential wall
stress to levels comparable with those of the reference group, and, therefore, outward remodeling was maladaptive.
Importantly, individuals who recovered from the MetS restored carotid properties to levels comparable to the reference
group, emphasizing the potential for reversibility. (Hypertension. 2012;60:542-549.) ● Online Data Supplement
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Individuals with the metabolic syndrome (MetS), that is,clustering of elevated blood pressure (BP), central obesity,
dyslipidemia, and impaired glucose metabolism, have an
increase risk of incident cardiovascular disease, in particular,
stroke.1 However, the underlying pathophysiology of the
MetS-stroke relationship remains poorly understood.
Numerous studies have linked the MetS to increased
carotid intima-media thickness (IMT)2 and or stiffness,3 and
both higher levels of carotid IMT and stiffness predict
incident cardiovascular disease, in particular, stroke.4,5 Mal-
adaptive arterial remodeling may also constitute a mechanism
linking the MetS to increased risk of stroke. Arterial remod-
eling, that is, the change of structural arterial properties over
time in response to hemodynamic and/or metabolic factors
operating within the arterial environment, is thought to be an
adaptive mechanism aiming at keeping shear stress within
certain limits.6 It is characterized by widening of the interad-
ventitial diameter (IAD) and increases in IMT. This process is
considered to be maladaptive when, despite remodeling,
circumferential wall tension (CWT) and stress (CWS; also
designated as tensile stress) remain elevated. Maladaptive
arterial remodeling has been linked to stroke by the observa-
tion of higher carotid CWT at the affected side of stroke
patients.7 Evidence thus far suggests that the MetS is associ-
ated with maladaptive arterial remodeling, but this is limited
because it derives from cross-sectional studies only,8–12 not
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all of which reported on CWT and/or CWS together with
IAD, lumen diameter (LD), and IMT.10–12
As snap-shots, cross-sectional studies do not enable a full
appreciation of dynamic processes, such as that of arterial
remodeling. For example, increases in IMT could precede
and lead to subsequent increases in IAD and/or LD, or,
alternatively, increases in IMT could result from increased
IAD. A longitudinal study is, thus, necessary for a better
understanding of the temporal relationships between carotid
IMT and diameter. In addition, the appreciation of accompa-
nying (changes in) levels of CWT and CWS can elucidate the
extent to which any such observed pattern of arterial remod-
eling is maladaptive. In view of these considerations, we have
examined changes in carotid artery structural and functional
properties and local hemodynamic forces as a function of
changes (in clustering of traits of) MetS status, in a 6-year
longitudinal study among apparently health adults.
Methods
Study Design and Population
Data were derived from the Amsterdam Growth and Health Longi-
tudinal Study, an ongoing observational longitudinal study that
started in 1976 with a total inclusion of 698 boys and girls (mean
age, 13.10.8 years), as described in detail elsewhere.13 In the year
2000, when subjects’ mean age was 36.6 years (0.6 years),
measurements of large artery properties by means of noninvasive
ultrasound were included for the first time in this cohort and obtained
in 373 subjects (baseline data of the present study).14–17 In 2006,
follow-ups of arterial measurements were obtained in 297 of these
individuals, 293 of whom had complete data on carotid artery
properties and traits of the MetS at both time points (the sample of
the present study). However, baseline characteristics from the 80
individuals without complete follow-up data did not differ from
those included (data not shown). Throughout the longitudinal period,
anthropometric (body height, weight, and waist circumferences),
biological (blood lipids and BP), and lifestyle (smoking status,
alcohol consumption, and physical activity levels) variables were
assessed according to standard procedures, as detailed else-
where.14–17 The medical ethical committee of the VU University
Medical Center in Amsterdam approved the study, and all of the
participants gave written informed consent.
Carotid Artery Properties and BP
At baseline and at follow-up, carotid properties were obtained by
means of the same protocol and ultrasound equipment, as described
in detail previously (please see online-only Data Supplement).14–17
LD was calculated as IAD(2 · IMT) and the arterial wall
cross-sectional (CSAIMT) as  · IMT · (IMTLD); CWT and CWS
were estimated according to Laplace’s law as MAP · (LD/2) and
CWT/IMT, respectively, where MAP is mean arterial pres-
sure.8,9,18,19 The Young’s elastic modulus (YEM) was estimated as
IAD/(IMT · DC), where DC indicates the distensibility coefficient,
which was calculated from IAD, distension, and local pulse
pressure.14–17
Throughout the entire period of ultrasound imaging, systolic
(SBP), diastolic (DBP), and MAP were assessed in the left arm at
5-minute intervals with oscillometric devices. Brachial pulse pres-
sure was defined as SBPDBP, and pulse pressure at the level of the
carotid artery was calculated by calibration of the diameter-
distension waveforms obtained at this and the brachial arteries, as
described by Van Bortel et al.20
Definition of the MetS and Changes in MetS
Status Over Time
At follow-up, subject levels of BP were obtained during the arterial
assessments only, that is, while subjects were in supine position. We,
therefore, deemed the use of the SBP/DBP cutoff values proposed by
established definitions of the MetS (eg, National Cholesterol Edu-
cation Program/International Diabetes Federation) inappropriate,
because these are based on readings in the sitting position, which are
higher. In addition, levels of fasting plasma glucose were not
available at baseline, and, therefore, we used glycated hemoglobin
(HbA1c) as a marker of glucose metabolism instead. The presence of
MetS traits was defined on the basis of the highest sex-specific
quartiles of SBP or DBP, waist circumference, triglycerides, and
HbA1c and the lowest sex-specific quartile of high-density lipopro-
tein cholesterol, as measured at baseline. The cutoff values thereby
derived are presented in Table S2 (available in the online-only Data
Supplement) and were used to classify presence or absence of MetS
traits at follow-up. Subjects were then assigned to 4 categories
according to the number of traits present, that is, 0, 1, 2, and 3, and
the latter category was used to identify individuals’ clustering of
traits indicative of the MetS (hereafter referred as “with MetS”).
Subjects were classified further into the following 4 groups of
changes in MetS status, including never (no MetS at baseline and
follow-up; n207), incident (MetS at follow-up but not at baseline;
n31), recovery (MetS at baseline but not at follow-up; n23), and
persistent (MetS at both baseline and follow-up; n32).
Statistical Analysis
We first examined the validity of the classification of participants’
MetS status as adopted herein by testing whether the observed
clustering of 3 traits occurred at levels above those that could be
dictated by chance alone.21 This was confirmed by an observed
prevalence of the MetS at baseline that was twice higher that which
could be expected by chance alone (Figure S1).
Generalized estimating equations, which is a statistical method
appropriate for analyses of repeated and, thus, correlated data,22
were used to test differences in carotid artery properties, at baseline
and at follow-up, and their changes over time between the 4 groups
of changes in MetS status. Groups were included in these analyses as
a dummy variable and differences tested relative to the reference
group (never); differences in changes, also relative to the reference
group, were tested by means of group · time interaction terms (model
specifications given in the online-only Data Supplement). All of the
analyses were adjusted for sex, height (as time-independent covari-
ates), and age, smoking, alcohol consumption, physical activity,
low-density lipoprotein cholesterol, and use of antihypertensive
medication (as time-varying covariates).22
All data are reported in men and women combined, because we
did not find any consistent significant interactions with sex. Trig-
lycerides levels, which were positively skewed, were loge trans-
formed before all data analyses. Statistical significance was set at
P0.05, and all analyses were carried out with the use of the STATA
software package version 11.2 (STATA Corp, College Station, TX).
Results
General characteristics of the study population, at baseline
and follow-up, are shown in Table 1, stratified by categories
of change in MetS status.
Carotid Properties and Their Changes by
Categories of Change in MetS Status
At baseline, individuals with persistent MetS had signifi-
cantly higher levels of IAD, LD, CWT, CWS, and YEM, but
not of IMT, than those who never developed the MetS (Table
2 and Figure). In the course of follow-up, the persistent MetS
group displayed significantly steeper increases in IMT (0.011
versus 0.005 mm/y), CSAIMT (0.38 versus 0.14 mm2/y), IAD
(0.077 versus 0.032 mm/y), and LD (0.055 versus 0.023
mm/y), whereas changes in CWT (0.33 versus 0.27 kPa/y),
CWS (0.34 versus 0.12 kPa/y), and YEM (0.010 versus
0.002 103 · kPa/y) did not significantly differ from those
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Table 1. Characteristics of the Study Population at Baseline and at Follow-Up by Categories of Changes in Metabolic
Syndrome Status
Characteristics Time
Metabolic Syndrome Status
Never (n207) Incident (n31) Recovery (n23) Persistent (n32)
Male sex, % 44.9 54.8 52.2 50.0
Age, y Baseline 36.50.6 36.30.7 36.80.5 36.70.6
Follow-up 42.60.6 42.40.7 42.80.6 42.70.6
Traits of the metabolic syndrome
Systolic blood pressure, mm Hg Baseline 113.610.3 120.210.7 121.38.7 126.914.6
Follow-up 113.510.1 124.515.3 117.611.2 125.017.0
Diastolic blood pressure, mm Hg Baseline 63.16.5 67.66.9 69.26.2 71.17.5
Follow-up 68.77.8 75.77.9 71.26.1 75.17.6
Waist circumference, cm Baseline 75.77.8 81.59.7 85.113.2 90.28.2
Follow-up 80.68.6 88.18.7 87.813.0 96.210.1
HDL cholesterol, mmol/L Baseline 1.480.35 1.440.33 1.120.26 1.090.25
Follow-up 1.810.42 1.630.39 1.540.32 1.360.36
Triglycerides, mmol/L Baseline 0.9 (0.7–1.3) 1.2 (0.8–1.5) 1.7 (1.1–2.1) 1.8 (1.5–2.9)
Follow-up 0.8 (0.7–1.1) 1.5 (1.1–2.1) 1.0 (0.7–1.2) 1.6 (1.1–2.4)
Glycated hemoglobin, % Baseline 5.20.4 5.30.4 5.40.4 5.50.4
Follow-up 5.30.2 5.70.9 5.40.2 5.60.3
Other risk factors
Body mass index, kg/m2 Baseline 23.22.6 24.92.8 26.33.7 28.03.0
Follow-up 23.62.9 25.92.6 26.43.9 29.24.0
LDL cholesterol, mmol/L Baseline 2.890.80 3.240.84 3.330.93 3.420.88
Follow-up 2.700.74 2.890.94 3.250.93 2.940.78
Smokers, % Baseline 19.8 19.4 17.4 43.8
Follow-up 12.1 22.6 17.4 28.1
Alcohol drinkers, % Baseline 89.4 93.5 91.3 78.1
Follow-up 92.8 93.5 95.7 81.3
Physical activity, 103 METs/wk Baseline 4.2 (2.6–6.3) 4.1 (2.2–6.4) 4.1 (3.4–6.7) 4.0 (2.6–6.5)
Follow-up 2.7 (2.3–3.1) 2.6 (2.3–3.1) 2.6 (2.4–3.3) 2.7 (2.1–3.1)
Antihypertensive treatment, % Baseline 1.0 0.0 4.3 9.7
Follow-up 1.9 6.5 0.0 18.9
Carotid artery properties
Interadventitial diameter, mm Baseline 6.810.55 7.080.46 7.000.57 7.070.83
Follow-up 7.010.62 7.310.56 7.200.55 7.511.00
Lumen diameter, mm Baseline 5.570.54 5.790.46 5.780.58 5.790.79
Follow-up 5.710.62 5.950.50 5.910.52 6.110.92
Intima-media thickness, mm Baseline 0.620.10 0.640.10 0.610.06 0.640.12
Follow-up 0.650.11 0.680.14 0.640.11 0.700.13
Wall cross-sectional area, mm2 Baseline 12.12.3 13.02.2 12.21.6 12.93.2
Follow-up 13.02.6 14.23.3 13.32.7 15.24.2
Circumferential wall tension, kPa Baseline 29.94.7 32.74.4 33.25.4 34.87.4
Follow-up 31.35.6 35.84.9 34.04.1 36.77.5
Circumferential wall stress, kPa Baseline 49.111.4 52.110.8 55.512.5 55.914.2
Follow-up 49.913.1 54.411.0 54.010.0 53.612.9
Young’s elastic modulus, 103 · kPa Baseline 0.430.12 0.460.13 0.460.15 0.500.14
Follow-up 0.440.15 0.520.14 0.500.14 0.560.20
Data are percentage, meanSD, or median (interquartile range). LDL indicates low-density lipoprotein; HDL, high-density lipoprotein.
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observed in the reference group. Still, at follow-up CWT,
CWT, CWS, and YEM remained significantly higher in the
group with persistent MetS versus those who never developed
the MetS. Individuals who recovered from the MetS had, at
baseline, higher levels of CWT and CWS than the group who
never developed the MetS but displayed favorable changes in
all of the carotid artery properties such that, at follow-up,
none of these differed significantly from the group who never
developed the MetS. On the other hand, individuals with
incident MetS displayed significantly steeper increases in
CWT (0.56 versus 0.27 kPa/y) and also more adverse patterns
of change in the other carotid properties (albeit not signifi-
cantly different), such that, at follow-up, these individuals
had significantly higher IAD, CWT, and YEM than those
who never developed the MetS.
Associations Between (Changes in) MetS Traits
and (Changes in) Carotid Properties
The associations of each trait of the MetS and their changes
(as continuous variables) with (changes in) carotid artery
properties are shown in Table 3 and can be summarized as
follows. At baseline, higher levels of IAD and LD were
primarily determined by higher levels of waist circumference,
whereas higher levels of CWT, CWS, and YEM were
determined by both higher levels of waist and BP; none of the
traits of the MetS were associated with increased IMT,
however. During the course of follow-up, increases in waist
circumference also determined steeper increases in IAD, LD,
and YEM, and increases in BP were main determinants of
increases in these properties but also of CWT and CWS.
Interestingly, increases in IMT were determined only by in-
creases in HbA1c, which was also implicated in steeper in-
creases in IAD and CSAIMT. Changes in blood lipids did not
affect changes in arterial properties.
Additional Analyses
When, as suggested,23 CWT and CWS were calculated at
levels of DBP instead of MAP (because IMT and IAD are
measured in diastole), we observed essentially the same
patterns of changes and differences across groups as reported
above (please see Figure S2).
Discussion
The main finding of our study is that individuals with
persistent MetS, as compared with individuals who never had
the MetS, displayed significantly steeper increases in IMT
and CSAIMT during the course of follow-up that were
preceded by elevated levels of IAD, LD, YEM, and CWT and
Table 2. Comparison of Carotid Artery Properties Across Categories of Changes in Metabolic Syndrome Status
Dependent Variable
Independent Variable:
MetS Status
Baseline Follow-Up 6-y 
 95% CI  95% CI  95% CI
IAD, mm Incident 0.202 0.001 to 0.405 0.247 0.045 to 0.448* 0.045 0.097 to 0.186
Recovery 0.137 0.094 to 0.368 0.139 0.093 to 0.371 0.002 0.159 to 0.163
Persistent 0.209 0.007 to 0.410* 0.477 0.278 to 0.677‡ 0.268 0.128 to 0.408‡
LD, mm Incident 0.158 0.039 to 0.353 0.187 0.009 to 0.382 0.029 0.121 to 0.179
Recovery 0.164 0.059 to 0.388 0.152 0.072 to 0.377 0.012 0.183 to 0.158
Persistent 0.183 0.002 to 0.364* 0.374 0.180 to 0.567‡ 0.191 0.042 to 0.339†
IMT, mm Incident 0.020 0.021 to 0.061 0.029 0.012 to 0.070 0.009 0.032 to 0.050
Recovery 0.017 0.064 to 0.030 0.010 0.057 to 0.037 0.007 0.040 to 0.054
Persistent 0.010 0.031 to 0.051 0.051 0.011 to 0.092* 0.041 0.001 to 0.082*
CSAIMT, mm
2 Incident 0.78 0.18 to 1.73 1.09 0.14 to 2.05* 0.33 0.53 to 1.18
Recovery 0.04 1.13 to 1.06 0.14 0.96 to 1.23 0.17 0.80 to 1.14
Persistent 0.63 0.33 to 1.58 2.03 1.05 to 3.00‡ 1.43 0.59 to 2.28†
CWT, kPa Incident 2.22 0.52 to 3.92* 3.97 2.28 to 5.67‡ 1.75* 0.29 to 3.21
Recovery 3.01 1.07 to 4.96† 2.11 0.16 to 4.06* 0.90 2.57 to 0.76
Persistent 5.11 3.39 to 6.84‡ 5.49 3.76 to 7.22‡ 0.38 1.11 to 1.87
CWS, kPa Incident 1.77 2.46 to 5.99 3.75 0.57 to 7.84 1.98 2.28 to 6.24
Recovery 5.77 0.94 to 10.58* 3.52 1.31 to 8.37 2.25 7.10 to 2.60
Persistent 7.21 2.91 to 11.51† 4.41 0.09 to 8.73* 2.80 7.11 to 1.52
YEM, 103 · kPa Incident 0.015 0.037 to 0.067 0.068 0.016 to 0.120* 0.050 0.008 to 0.109
Recovery 0.018 0.041 to 0.077 0.049 0.011 to 0.109 0.031 0.038 to 0.098
Persistent 0.060 0.007 to 0.113* 0.117 0.066 to 0.168‡ 0.048 0.011 to 0.107
 indicates regression coefficient: indicates differences in carotid artery property as compared with referent group (ie, never); IAD, interadventitial diameter; LD,
lumen diameter; IMT, intima-media thickness; CSAIMT, wall cross-sectional area; CWT, circumferential wall tension; CWS, circumferential wall stress; YEM, Young’s
elastic modulus. All data are adjusted for age, sex, body height and (changes in) smoking status, alcohol consumption, physical activity, low-density lipoprotein
cholesterol, and use of antihypertensive medication.
*P0.05.
†P0.01.
‡P0.001.
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CWS already at baseline. This suggests that, among young
individuals without overt signs of atherosclerosis, arterial
enlargement and stiffening may precede and favor subsequent
wall thickening to restore normal levels of wall tensile stress.
Indeed, during the course of follow-up, IAD and LD in-
creased further, and CWS tended to decrease among individ-
uals with persistent MetS, although it remained significantly
higher than that observed in individuals who never developed
the MetS. Therefore, this pattern of arterial outward remod-
eling remained, to an important extent, maladaptive. Notably,
in individuals who recovered from the MetS, all of the carotid
artery properties were restored to levels that no longer
differed from those who never developed the MetS. This is an
important observation, because it points toward the revers-
ibility of a pathobiological process that, if not interrupted in
time, may carry adverse health consequences, such as stroke.
To our knowledge, this is the first study that has examined,
with a truly longitudinal design, the life course and temporal
relationships between carotid artery structural and functional
properties and local hemodynamic factors as a function of
changes in the MetS. Being conducted among apparently
healthy and young adults, our findings likely describe the
early stages of accelerated arterial aging related to the MetS.
Changes in carotid IMT and distension as a function of
changes in MetS over the course of 6 years among apparently
healthy adults of comparable age have been reported recently
in a large (n1673), population-based study.24 Our findings
are in agreement with this study, regarding the following: (1)
the rates of changes in MetS status (never [74% versus 71%],
incident [12% versus 11%], recovery [4% versus 8%], and
persistent [10% versus 11%], respectively); (2) the patterns of
changes in MetS traits (eg, steeper increase in DBP than
SBP), even those that, at first glance, could seem counterin-
tuitive (eg, overall increases in mean levels of high-density
lipoprotein cholesterol with aging); and (3) the patterns of
changes in IMT that were also steeper in those with persistent
MetS only. We, thus, believe our findings, despite having
been obtained with an adapted criterion to define MetS and in
a smaller sample, do reflect true MetS-related arterial changes
that occur in the course of young adult life. Data on
concomitant changes in arterial diameter and hemodynamic
forces were not provided in that study, however, thus not
enabling the appreciation of MetS-related arterial remodeling
processes.
Our study investigated these variables and raised the
question of whether increases in IMT in the context of
persistent MetS reflect atherosclerosis, concluding that wall
thickening could primarily reflect an adaptive mechanism
that attempted to restore local hemodynamic conditions to an
equilibrium rather than atherosclerosis, per se. Indeed, it has
been proposed that, at levels0.9 mm, increases in IMT may
reflect adaptive arterial remodeling.6,25 Still, because the
observed pattern of outward remodeling was maladaptive, our
findings may have implications for cardiovascular risk, par-
ticularly stroke. Indeed, 3 different patterns of arterial remod-
eling have been identified: inward (decrease in LD resulting
from greater increase in IMT than IAD), outward (increase in
LD because of greater change in IAD than IMT), and
compensatory (LD preservation despite changes in IAD and
IMT).26 Of these, inward and outward have been linked to
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stable and unstable plaque formation, respectively.26,27 In
addition, among several carotid geometric patterns, a pattern
of hypertrophy with dilation, which is, thus, equivalent to the
outward remodeling described in the present study, was also
linked to the highest incidence of cardiovascular disease
among elderly participants of the Cardiovascular Health
Study.28 Although the extent to which young adults with the
MetS showing signs of maladaptive outward remodeling are
more likely to develop such kind of atherosclerotic compli-
cations later in life is not known, these observations empha-
size the clinical relevance of our findings. It further stresses
the potential need for early preventive measures, because we
observed that recovery from MetS led to reversibility of
maladaptive outward remodeling. This resulted from benefi-
cial changes in MetS traits, in particular, DBP, waist circum-
ference, and HbA1c (Table S3 and Figure S3), all of which
contributed also to arterial adaptations (Table 3).
Because of the longitudinal design, we obtained a better
insight into the sequence of carotid structural and functional
adaptations related to the MetS. The observation that persis-
tent MetS was not only associated with increased IAD and
LD but also YEM (a marker of the elastic properties of the
arterial wall material) already at baseline, suggests that loss of
elasticity at the level of the media layer (ie, arteriosclerosis)
could explain the arterial enlargement of individuals with the
MetS. Consequently, the subsequent increases in IMT and
CSAIMT could reflect wall changes occurring primarily at the
level of the media rather than the intima (atherosis) layer.
Increases in CSAIMT (although not IMT) were related to
changes in SBP, and increases in IAD and LD were associ-
ated with both changes in SBP and DBP but more strongly
with the former than the latter (Table 3). This points toward
a stronger impact of the pulsatile component of BP on arterial
remodeling. Indeed, when we additionally examined the
extent to which the steeper increases in IAD, LD, IMT, and
CSAIMT observed among individuals with persistent MetS
could be explained by concomitant changes in BP, we
observed that these were not affected when further adjusted
for changes in DBP but were somewhat attenuated when
adjusted for changes in local pulse pressure (Table S4).
Transmural pressure exerts a fatiguing effect on the load-
bearing elements of the arterial wall (ie, elastin and collagen),
leading to degenerative changes and fracture of the extracel-
lular matrix component that result in arterial enlargement.23
Nevertheless, the steeper increases in IAD, LD, IMT, and
CSAIMT in individuals with persistent versus never MetS
remained statistically significant after adjustments for BP,
suggesting that other factors may be involved. Indeed, we
observed that increases in these arterial properties were also
determined by changes in HbA1c. This could reflect under-
lying cross-links between molecules in the arterial wall
because of advanced-glycation end products, thereby contrib-
Table 3. Associations Between (Changes in) Each Metabolic Syndrome Trait and (Changes in) Carotid Artery Properties
Independent Variable Time
Dependent Variable
IAD, mm LD, mm IMT, mm CSAIMT, mm
2 CWT, kPa CWS, kPa YEM, 103 · kPa
Systolic blood pressure Baseline 0.005 0.016 0.008 0.15 2.62‡ 3.81‡ 0.039‡
Follow-up 0.091‡ 0.070† 0.015† 0.52‡ 3.51‡ 4.30‡ 0.078‡
 per y 0.016‡ 0.014† 0.001 0.06* 0.15‡ 0.08 0.006‡
Diastolic blood pressure Baseline 0.035 0.018 0.010 0.27* 2.74‡ 3.85‡ 0.040‡
Follow-up 0.094‡ 0.085‡ 0.008 0.36† 3.68‡ 5.23‡ 0.074‡
 per y 0.010* 0.011† 0.000 0.02 0.16‡ 0.23* 0.006‡
Waist circumference Baseline 0.066* 0.058* 0.005 0.23 1.19‡ 1.81† 0.019*
Follow-up 0.118‡ 0.102‡ 0.009 0.46† 1.51‡ 1.74† 0.045‡
 per y 0.009* 0.007* 0.001 0.04 0.05 0.01 0.004†
HDL cholesterol Baseline 0.018 0.021 0.001 0.01 0.43 0.78 0.008
Follow-up 0.002 0.012 0.004 0.05 0.39 0.75 0.011
 per y 0.003 0.002 0.001 0.01 0.01 0.00 0.000
Ln-triglycerides Baseline 0.005 0.005 0.003 0.06 0.58* 1.23* 0.014
Follow-up 0.040 0.053* 0.004 0.03 0.60† 1.13 0.023†
 per y 0.008 0.008 0.000 0.02 0.00 0.02 0.002
Glycated hemoglobin Baseline 0.034 0.014 0.007 0.22 0.19 0.27 0.000
Follow-up 0.016 0.003 0.005 0.13 0.10 0.27 0.005
 per y 0.009* 0.007 0.002* 0.06* 0.05 0.09 0.001
Data are standardized regression coefficients and indicate the differences in carotid artery property per SD increase in MetS trait; this enables comparison of the
strength of the associations with carotid properties between traits; IAD, interadventitial diameter; Ln, natural logarithm; HDL, high-density lipoprotein; LD, lumen
diameter; IMT, intima-media thickness; CSAIMT, wall cross-sectional area; CWT, circumferential wall tension; CWS, circumferential wall stress; YEM, Young’s elastic
modulus. All of the data are adjusted for age, sex, body height and (changes in) smoking status, alcohol consumption, physical activity, low-density lipoprotein
cholesterol, and use of antihypertensive medication.
*P0.05.
†P0.01.
‡P0.001.
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uting directly to accelerated arterial stiffening, as commonly
observed among patients with (pre)diabetes mellitus.3 How-
ever, HbA1c was not related to YEM, a marker of the
intrinsic elastic wall material. In addition, metabolic factors
related to central adiposity, yet another MetS trait related to
changes in IAD, LD, and YEM, can also play an additional
disrupting role in the intricate process of arterial remodeling.
These may include adipocytokine or systemic inflammatory
factors, oxidative stress, vascular smooth muscle cell growth,
and stimulation of the sympathetic nervous system.3,16 All
together these observations suggest that clustering of elevated
BP, abdominal obesity, and impaired glucose metabolism
may constitute a phenotype with the most adverse impact on
arterial properties. This is in line with earlier cross-sectional
observations,9 but because of the relatively small sample of
the present study, we could not examine arterial changes
associated with specific clusters of MetS traits further.
There are additional limitations to our study. First, ultra-
sound does not distinguish the intima from the media layers
of the carotid wall, thus not enabling full insight on whether
wall thickening related to MetS was particularly associated
with atherosis (intima) or arteriosclerosis (media). Second,
IMT was measured at one arterial site, and although we took
measures to ensure that follow-up examinations did not differ
from baseline in this regard, at both time points, our measures
do not capture possible variability in IMT along the arterial
wall. Third, although good levels of reproducibility were
obtained between observers involved in the baseline (I.F.)
and the follow-up (F.S.) examinations, data on changes in
arterial properties may have been obtained with some error. If
anything, this may have led to an underestimation of the
associations reported herein, because both at baseline and at
follow-up observers were unaware of participants’ metabolic
risk profiles (ie, nondifferential error). Fourth, the prevalence
of the MetS as reported herein may not compare directly with
that obtained with standard definitions, because it was esti-
mated on the basis of risk factor distribution within the study
population. Still, it served the purpose of identification of a
phenotype (clustering of elevated MetS traits) and its change
over time, which is suitable for the study of an etiologic
research question, that is, its association with arterial remod-
eling. Last, our findings were obtained in relatively young
and apparently healthy white adults and should be interpreted
with caution with regard to older and higher-risk populations
and other ethnicities.
Perspectives
We identified a pattern of outward carotid remodeling (ie,
diameter widening and wall thickening, in this order) among
individuals with persistent versus never MetS over the course
of 6-year follow-up. This process was maladaptive because,
despite remodeling, wall tensile stress was not restored to
levels comparable to those who never had the MetS. Impor-
tantly, reversibility of maladaptive outward remodeling was
achieved by recovery from the MetS. Maladaptive carotid
remodeling may carry important implications for cardiovas-
cular risk, particularly stroke. Prospective studies investigat-
ing the link between patterns of arterial remodeling in young
adults with future cardiovascular outcome are further needed,
to decide on the usefulness of screening and implementation
of appropriate preventive measures likely to deter related
cardiovascular sequelae.
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Novelty and Significance
What Is New?
● We studied changes in carotid structural, functional, and local hemody-
namic factors as a function of changes in MetS status over the course
of 6-years follow-up.
● Given the longitudinal design, we could examine the temporal relation-
ships between diameter and wall thickening and concomitant hemody-
namic factors.
What Is Relevant?
● We observed the development of a pattern of maladaptive outward
carotid remodeling among individuals with persistent MetS and a similar
trend among individuals with incident MetS.
● Recovery from the MetS restored initial adverse carotid adaptations to
levels comparable to those who never developed the MetS. Wall
thickening was preceded by wall widening.
Summary
The development of maladaptive outward remodeling may explain
the increased risk of cardiovascular disease, in particular, stroke,
in individuals with the MetS.
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